Drug Pricing Turns to Insulin As Politicians, AMA And Docs Look to Pharma

Those huge pharma companies control the market for insulin, an age-old drug that millions of diabetic patients need to function on a daily basis. Estimates of those with diabetes in the United States top 30 million.